Bioengineered probiotics to control SARS-CoV-2 infection

The outbreak of 2019 novel corona virus disease (COVID-19) is now a global public health crisis and declared as a pandemic. Several recent studies suggest that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein binds to human angiotensin-converting enzyme 2 (ACE2). The inform...

Full description

Bibliographic Details
Main Authors: Shantibhusan Senapati, Jayalaxmi Dash, Manisha Sethi, Subhankar Chakraborty
Format: Article
Language:English
Published: Pensoft Publishers 2020-05-01
Series:Research Ideas and Outcomes
Subjects:
Online Access:https://riojournal.com/article/54802/download/pdf/